| 摘要 |
The present invention is directed to a compound of Formula (I):, and pharmaceutically acceptable salts, solvates, hydrates or stereoisomers thereof, which are useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases. |
| 申请人 |
ELI LILLY AND COMPANY;CONNER, SCOTT, EUGENE;GOSSETT, LYNN, STACY;GREEN, JONATHAN, EDWARD;JONES, WINTON, DENNIS JR.;MANTLO, NATHAN, BRYAN;MATTHEWS, DONALD, PAUL;MAYHUGH, DANIEL, RAY;SMITH, DARYL, LYNN;VANCE, JENNIFER, ANN;WANG, XIAODONG;WARSHAWSKY, ALAN, M;WINNEROSKI, LEONARD, LARRY JR.;XU, YANPING;ZHU, GUOXIN |
发明人 |
CONNER, SCOTT, EUGENE;GOSSETT, LYNN, STACY;GREEN, JONATHAN, EDWARD;JONES, WINTON, DENNIS JR.;MANTLO, NATHAN, BRYAN;MATTHEWS, DONALD, PAUL;MAYHUGH, DANIEL, RAY;SMITH, DARYL, LYNN;VANCE, JENNIFER, ANN;WANG, XIAODONG;WARSHAWSKY, ALAN, M;WINNEROSKI, LEONARD, LARRY JR.;XU, YANPING;ZHU, GUOXIN |
